» Articles » PMID: 18162610

Oxidant Generation Predominates Around Calcifying Foci and Enhances Progression of Aortic Valve Calcification

Overview
Date 2007 Dec 29
PMID 18162610
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We hypothesized that reactive oxygen species (ROS) contribute to progression of aortic valve (AV) calcification/stenosis.

Methods And Results: We investigated ROS production and effects of antioxidants tempol and lipoic acid (LA) in calcification progression in rabbits given 0.5% cholesterol diet +10(4) IU/d Vit.D2 for 12 weeks. Superoxide and H2O2 microfluorotopography and 3-nitrotyrosine immunoreactivity showed increased signals not only in macrophages but preferentially around calcifying foci, in cells expressing osteoblast/osteoclast, but not macrophage markers. Such cells also showed increased expression of NAD(P)H oxidase subunits Nox2, p22phox, and protein disulfide isomerase. Nox4, but not Nox1 mRNA, was increased. Tempol augmented whereas LA decreased H2O2 signals. Importantly, AV calcification, assessed by echocardiography and histomorphometry, decreased 43% to 70% with LA, but increased with tempol (P < or = 0.05). Tempol further enhanced apoptosis and Nox4 expression. In human sclerotic or stenotic AV, we found analogous increases in ROS production and NAD(P)H oxidase expression around calcifying foci. An in vitro vascular smooth muscle cell (VSMC) calcification model also exhibited increased, catalase-inhibitable, calcium deposit with tempol, but not with LA.

Conclusions: Our data provide evidence that ROS, particularly hydrogen peroxide, potentiate AV calcification progression. However, tempol exhibited a paradoxical effect, exacerbating AV/vascular calcification, likely because of its induced increase in peroxide generation.

Citing Articles

Association between dietary niacin intake and abdominal aortic calcification among the US adults: the NHANES 2013-2014.

Zhang J, Li M, Wang X, Wang T, Tian W, Xu H Front Nutr. 2024; 11:1459894.

PMID: 39668898 PMC: 11634585. DOI: 10.3389/fnut.2024.1459894.


An emerging double‑edged sword role of ferroptosis in cardiovascular disease (Review).

Qin S, Zhu C, Chen C, Sheng Z, Cao Y Int J Mol Med. 2024; 55(1).

PMID: 39540363 PMC: 11573318. DOI: 10.3892/ijmm.2024.5457.


Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress.

Ballester-Servera C, Alonso J, Canes L, Vazquez-Sufuentes P, Garcia-Redondo A, Rodriguez C Antioxidants (Basel). 2024; 13(5).

PMID: 38790628 PMC: 11118817. DOI: 10.3390/antiox13050523.


Models for calcific aortic valve disease in vivo and in vitro.

Zhu Z, Liu Z, Zhang D, Li L, Pei J, Cai L Cell Regen. 2024; 13(1):6.

PMID: 38424219 PMC: 10904700. DOI: 10.1186/s13619-024-00189-8.


Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease.

Wang X, Wang Z, He J Diabetes Metab Syndr Obes. 2024; 17:165-192.

PMID: 38222032 PMC: 10788067. DOI: 10.2147/DMSO.S438618.